FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chelated mercury complexes with cysteine of formula C6H13O4N2S2HgCl or methionine of formula C10H21O4N2S2HgCl which show anticancer, antiviral, antiparasitic and immunomodulating action. The invention also concerns a method for preparing the complexes specified above which involves conducting a reaction of mercury dichloride and an aqueous solution of cysteine or methionine, keeping the mixture at temperature 35-40°C for 60-90 min, cooling the reaction mixture to 18-20°C and setting at this temperature for one day. The invention also refers to a drug preparation that is an apoptosis modulator of showing anticancer, antiviral, immunomodulating and antiparasitic action which contains the chelated mercury complex with cysteine or methionine 0.38-0.52 wt % and distilled water.
EFFECT: invention provides preparing the new chelated mercury complexes showing anticancer, antiviral, antiparasitic and immunomodulating action, and also the simplified method for preparing them at lower temperatures.
6 cl, 8 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING HIV-INFECTED PATIENTS | 2003 |
|
RU2237484C1 |
METHOD OF TREATING REACTIVATED FORM OF UROGENITAL CYTOMEGALOVIRAL INFECTION IN FEMALES OF REPRODUCTIVE AGE | 2013 |
|
RU2513474C1 |
IMMUNOMODULATING REMEDY | 1993 |
|
RU2034542C1 |
PHARMACEUTICAL AGENT OF PLANT ORIGIN IN THE FORM OF A SPRAY | 2022 |
|
RU2801872C1 |
DRUG PREPARATION IN SUPPOSITORIES FOR INFECTIOUS-INFLAMMATORY DISORDERS CAUSED BY TYPE 1 HERPES SIMPLEX AND CYTOMEGALOVIRUS, AND METHOD FOR USING IT FOR TREATING CHILDREN | 2013 |
|
RU2521272C1 |
CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
APOPTOSIS-INDUCING AGENTS AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2709498C1 |
METHOD OF COMPLEX THERAPY OF PRE-INVASIVE AND INVASIVE CERVICAL CANCER | 2013 |
|
RU2560689C2 |
PHARMACEUTICAL ANTI-HERPETIC COMPOSITION AND METHOD FOR OBTAINING MEDICINAL FORM UPON ITS BASIS | 2003 |
|
RU2264819C2 |
METHOD FOR TREATMENT OF EARLY AGE CHILDREN WITH CYTOMEGALOVIRUS (CMV) INFECTION | 2004 |
|
RU2272645C2 |
Authors
Dates
2012-07-20—Published
2010-02-26—Filed